Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Received for publication June 15, 2006
- Accepted for publication August 14, 2006
- Published online November 30, 2006.
Copyright & Usage
© 2006 by Society of Nuclear Medicine
Author Information
- Damian Wild 1 ,
- Martin Béhé 2 ,
- Andreas Wicki 3 ,
- Daniel Storch 4 ,
- Beatrice Waser 5 ,
- Martin Gotthardt 2 ,
- Boris Keil 6 ,
- Gerhard Christofori 3 ,
- Jean Claude Reubi 5 and
- Helmut R. Mäcke 4
- 1Clinic and Institute of Nuclear Medicine, University Hospital Basel, Basel, Switzerland; 2Department of Nuclear Medicine, Hospital of the Philipps-University, Marburg, Germany; 3Institute of Biochemistry and Genetics, Center for Biomedicine, University of Basel, Basel, Switzerland; 4Division of Radiological Chemistry, University Hospital Basel, Basel, Switzerland; 5Institute of Pathology, University of Bern, Bern, Switzerland; and 6Department of Radiology, Hospital of the Philipps-University, Marburg, Germany
- For correspondence or reprints contact: Helmut R. Mäcke, PhD, Division of Radiological Chemistry, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland. E-mail: hmaecke{at}uhbs.ch
Cited By...
Article usage
[Lys40(Ahx-DTPA-111In)NH2]Exendin-4, a Very Promising Ligand for Glucagon-like Peptide-1 (GLP-1) Receptor Targeting
Jump to section
Related Articles
Cited By...
- Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes
- Nintedanib Is a Highly Effective Therapeutic for Neuroendocrine Carcinoma of the Pancreas (PNET) in the Rip1Tag2 Transgenic Mouse Model
- Development of 68Ga- and 89Zr-Labeled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET
- The Glucose-Dependent Insulinotropic Polypeptide Receptor: A Novel Target for Neuroendocrine Tumor Imaging--First Preclinical Studies
- GLP-1R-Targeting Magnetic Nanoparticles for Pancreatic Islet Imaging
- In Vivo Imaging of the Glucagonlike Peptide 1 Receptor in the Pancreas with 68Ga-Labeled DO3A-Exendin-4
- Development and Evaluation of 18F-TTCO-Cys40-Exendin-4: A PET Probe for Imaging Transplanted Islets
- PET of Glucagonlike Peptide Receptor Upregulation After Myocardial Ischemia or Reperfusion Injury
- Glucagon-Like Peptide-1 Versus Somatostatin Receptor Targeting Reveals 2 Distinct Forms of Malignant Insulinomas
- Exendin-4-Based Radiopharmaceuticals for Glucagonlike Peptide-1 Receptor PET/CT and SPECT/CT
- Nephrotoxicity in Mice After Repeated Imaging Using 111In-Labeled Peptides
- Generation of Novel Single-Chain Antibodies by Phage-Display Technology to Direct Imaging Agents Highly Selective to Pancreatic {beta}- or {alpha}-Cells In Vivo
- [Lys40(Ahx-DTPA-111In)NH2]-Exendin-4 Is a Highly Efficient Radiotherapeutic for Glucagon-Like Peptide-1 Receptor-Targeted Therapy for Insulinoma
- GLP-1 Receptor Expression in Human Tumors and Human Normal Tissues: Potential for In Vivo Targeting
- Receptor-Mediated Tumor Targeting with Radiolabeled Peptides: There Is More to It than Somatostatin Analogs